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Abstract
Background: microRNAs play important roles in various biological processes involving fairly complex mechanism. Analysis
of genome-wide miRNA microarray demonstrate that a single miRNA can regulate hundreds of genes, but the regulative
extent on most individual genes is surprisingly mild so that it is difficult to understand how a miRNA provokes detectable
functional changes with such mild regulation.
Results: To explore the internal mechanism of miRNA-mediated regulation, we re-analyzed the data collected from
genome-wide miRNA microarray with bioinformatics assay, and found that the transfection of miR-181b and miR-34a in
Hela and HCT-116 tumor cells regulated large numbers of genes, among which, the genes related to cell growth and cell
death demonstrated high Enrichment scores, suggesting that these miRNAs may be important in cell growth and cell death.
MiR-181b induced changes in protein expression of most genes that were seemingly related to enhancing cell growth and
decreasing cell death, while miR-34a mediated contrary changes of gene expression. Cell growth assays further confirmed
this finding. In further study on miR-20b-mediated osteogenesis in hMSCs, miR-20b was found to enhance osteogenesis by
activating BMPs/Runx2 signaling pathway in several stages by co-repressing of PPARc, Bambi and Crim1.
Conclusions: With its multi-target characteristics, miR-181b, miR-34a and miR-20b provoked detectable functional changes
by co-regulating functionally-related gene groups or several genes in the same signaling pathway, and thus mild regulation
from individual miRNA targeting genes could have contributed to an additive effect. This might also be one of the modes of
miRNA-mediated gene regulation.
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Introduction
miRNAs are a class of small non-coding RNAs, which play
pivotal roles in various biological processes including cell fate
choices of embryonic stem cells, cell proliferation, apoptosis,
development, differentiation, morphogenesis, carcinogenesis and
angiogenesis[3–14]. Mature miRNAs repress gene expression
post-transcriptionally by binding to regulatory targets in the 3-
untranslated regions (39UTRs) of mRNAs, then leading to
translational repression or mRNA degradation [3,15]. Some
different action modes were also reported in a few mRNAs,
including transcriptionally inducing or silencing gene expression
through binding to target sites in the promoter region of a gene
[16,17]. Recently, Eiring et al. reported that miR-328 can act as a
decoy by binding to a regulatory RNA binding protein and
preventing it from blocking translation of mRNAs [18]. However,
post-transcriptionally repressing gene expression by binding to
39UTRs is still the mainstream regulative mode of miRNAs and
the complexity of this mode is gradually emerging.
Computational prediction and biologic data from investigations
of genome-wide scale show that one miRNA may target tens to
hundreds of genes [19–21]. Recently data gathered using a
proteomic approach also demonstrated that a single miRNA can
repress the production of hundreds of proteins, but the extent of
miRNA-mediated repression is surprisingly mild[1,2], so it is
difficult to understand how a single miRNA is able to provoke a
detectable functional change, with such a mild regulation. This
widespread, often subtle and customized, influence of miRNAs on
mRNA expression was introduced by Bartel and Chen as the
‘micromanager model’ or ‘tuning’ of miRNA function [22].
PLoS ONE | www.plosone.org 1 October 2010 | Volume 5 | Issue 10 | e13558‘‘Tuning’’ gene’s expression to keep balance might be one of the
important functions of miRNAs, however, it seems hard to
reconcile with the reported critical functions of miRNAs in a
broad range of biological and pathological processes. Seitz
proposed that miRNAs can not fine-tune many targets, because
many computationally identified miRNA targets may actually be
competitive inhibitors of miRNA function, preventing miRNAs
from binding their authentic targets by sequestering them.
miRNAs would rather repress only a few authentic targets, but
those targets would be repressed sufficiently for that regulation to
have a physiological effect [23]. Here, we propose that fine-tuning
target expression can have a large effect, by co-regulating
functionnally related genes under certain conditions. However,
evidences are needed to support this hypothesis.
In this study, we re-analyzed the data from investigations of
genome-wide scale by employing a bioinformatic assay[1,24], and
found that the transfection of a single miR-181b or miR-34a in
Hela or HCT 116 tumor cells regulated large numbers of genes.
Among them, the genes related to cell growth and cell death
displayed high Enrichment scores, suggesting that these two
miRNAs may be involved in cell growth and cell death, and that
was confirmed using biological assays. In our further study on
miR-20b mediated osteogenesis in hMSCs, we found that miR-
20b enhances osteogenesis by activating several levels of the
BMPs/Runx2 signaling pathway, which includes co-repressing
PPARc, Bambi and Crim1. Our data suggests that miR-181b,
miR-34a and miR-20b co-regulate a group of functionally related
genes to provoke detectable functional changes under certain
condition.
Results and Discussion
miR-181b and miR-31a co-regulate large numbers of
functionally related genes to cause functional changes of
the cells
In order to investigate if there is a co-regulative pattern in miRNA-
mediated functional change, we studied the effect of miR-181b and
miR-31a on cell growth and cell death. First, we re-analyzed the
biologic data from investigations of genome-wide scale [1,24], using a
bioinformatics program called DAVID [25] and grouped miRNA
regulated genes into functional annotation clusters. If co-regulative
pattern plays a role in miR-181b- and miR-34a-mediated cell growth
or death, the gene clusters related to cell growth and cell death would
have high Enrichment scores. According to the study by Lempicki
and coworkers, a higher Enrichment score for a cluster indicates that
t h eg e n em e m b e r si nt h ec l u s t e ra r ei n v o l v e di nm o r ei m p o r t a n t
(enriched) terms in a given study [25].
Bartel and coworkers used quantitative mass spectrometry to
measure the response of thousands of proteins after introducing
miR-181b into Hela cells [1]. We analyzed their proteomic data
with DAVID bioinformatics resources and found that a total of
674 genes were regulated by miR-181b when cut off value was
60.2 (log2-fold-change), corresponding to a 15% change. We
uploaded all of these genes into DAVID bioinformatics resources
for functional annotation clustering. The result showed that five
clusters are related to cell growth and cell death, and their
Enrichment scores are 4.1, 2.23, 2.22, 1.79 and 1.64, all higher
than 1.3 (Table S1). An enrichment score of 1.3 is equivalent to a
non-log scale value of 0.05. More attention should be given to
groups with scores $1.3 [25]. These results suggest that miR-181b
may regulate cell growth and cell death.
After removing the overlapping genes among the five clusters,
we found 153 genes related to cell growth and cell death (Table
S2). Among them, 86 genes are down regulated and 67 genes are
up regulated; 109 genes (N+P) are reported positively or negatively
regulating cell growth or death and the other 44 (D) may have dual
effects or unclear effects on cell activities (Table 1 and Table S2).
Among 76 genes that have been previously determined to
stimulate cell growth or inhibit cell death, 42 genes were up-
regulated (Table 1). On the other hand, 25 out of 33 genes that
can inhibit cell growth or promote apoptosis were down regulated.
Thus, miR-181b induced a change in protein expression of 67 out
of 109 (61.5%) genes related to enhancing cell growth and
decreasing cell death. Our data suggests that miR-181b may
stimulate Hela cell growth and inhibit cell death. However the
exact function of this miRNA on cell growth depends on the
comprehensive effect of miR-181b regulated genes, and not on the
number of miRNA regulated genes that are predicted to activate
cell growth or inhibit cell death, so thus biological assays should be
used to confirm the exact roles of miR-181b in Hela cells.
In order to confirm the role of miR-181b in cell growth, we
transfected Hela cells with the mimic of miR-181b and evaluated
the effect of miR-181b transfection on cell growth and death, a
mimic with random sequence (NC) was used as control. The cells
transfected with miR-181b grew faster than the control (Fig. 1A).
We also studied the role of miR-181b in inducing cell growth in
CNE cells, a nasopharyngeal carcinoma cell line (Fig. 1B).
Nakagama and co-workers reported that miR-34a caused
complete suppression of cell proliferation and apoptosis in HCT
116 cells. They transiently introduced miR-34a into two human
colon cancer cell lines, HCT 116 and RKO for gene-expression
microarray assay [18]. We analyzed the biologic data from miR-
34a-transfected HCT 116 cells with the DAVID bioinformatics
resources [25] and found that 451 genes were regulated by miR-
34a when the value of change in gene expression was cut off at 2
folds. Functional annotation clustering then demonstrated that six
clusters were related to cell growth and cell death, and that the
Enrichment scores of these clusters are 5.77, 2.62, 1.91, 1.71, 1.52
Table 1. Effect miR-181b induced genes on cell growth and cell death.
Effect on cell growth or cell death Up-regulated genes Down-regulated genes Total
P 42 (a) 34 (b) 76
N 8 (c) 25 (d) 33
D 17 (e) 27 (f) 44
total 67 86 153
P: stimulating cell growth or inhibiting cell death;
N: inhibiting cell growth or enhancing cell death;
D: dual effects or unclear effects on cell growth or cell death.
doi:10.1371/journal.pone.0013558.t001
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them are related to cell cycle or cell death (after removing the
overlapping genes). Among them, 59 genes were down regulated
and 61 genes were up regulated through direct or indirect
interaction with miR-34a (Table S4). With the exception of 36
genes that have been suggested to exert dual effects or unclear
effects on cell growth or cell death (D), 85 genes (N+P) were to
positively or negatively affect cell growth or cell death (Table 2 and
Table S4). Amongst those 85, miR-34a altered the gene expression
of 52 of them (61.2%) all related to inhibiting cell growth and
enhancing apoptosis. This data suggests that miR-34a could
potentially inhibit cell growth and enhance apoptosis of HCT-116
cells. Since the comprehensive effect of the miRNA on cell growth
also depends on the quantitative effect of each of those miR-34a
regulated genes on cell growth, biological assays are needed to
confirm the exact role of miR-34a on HCT-116 cells. Nakagama’s
findings [18] and the results from our investigation are consistent
with what was found in the bio-informatics assay, all demonstrat-
ing that miR-34a can inhibit HCT-116 cell growth and enhance
apoptosis (Fig. 1C).
Taken together, miR-181b and miR-34a were able to cause an
obvious change in cell proliferation and/or apoptosis by co-
regulating a large number of cell growth- and cell death-related
genes, which together, exerted an accumulative effect. However,
an issue with transfecting miRNA in cultured cells is that they can
produce excessive miRNA concentrations that are far greater than
the physiological concentrations found in biological settings. As a
result, changes in cell physiology or morphology due miRNA
transfection may be different from the effects caused by an
endogenous miRNA.
miR-20b co-regulates several genes in the same signaling
pathway to generate functional changes of the cells
In previous experiments, we found that miR-20b can enhance
osteogenesis in human mesenchymal stem cells (hMSCs). Since
BMP/Runx2 signaling is critical in regulating osteoblast differen-
tiation [26], in this investigation, we studied if and how miR-20b
caused significant change in MSC differentiation by co-regulating
various genes in the BMPs/Runx2 signalingpathway to accumu-
late the mild regulation from individual miRNA target genes and
produce an accumulative effect as a whole.
As revealed by RT-PCR and ELISA, transfection of miR-20b
into hMSCs significantly elevated expression levels of BMP-2 and
Runx2 both at the mRNA and the protein levels (Fig. 2). Usually,
miRNAs negatively regulate gene expression. Therefore, it is
possible that miR-20b up-regulates the expression of both BMP2
and Runx2 by suppressing their negative regulators or inhibitors.
Among the negative regulators or inhibitors of BMP/Runx2
Figure 1. Cell growth assay of miR-181b- and miR-34a-transfected tumor cells. Hela cells (A), CNE cells (B) and HCT 116 cells (C) were
transfected with the mimics of miR-181b, miR-34a and miR-210. Small RNA with random sequence (NC) was used as a control. Cells were cultured for
three days and cell numbers were counted every day (A and C) or SRB (sulforhodamin B) was used for cell growth assay (B).
doi:10.1371/journal.pone.0013558.g001
Table 2. Effect miR-34a induced genes on cell growth and cell death.
Effect on cell growth or cell death Up-regulated genes Down-regulated genes Total
P 20 (a) 31 (b) 51
N 21 (c) 13 (d) 34
D 20 (e) 15 (f) 35
total 61 59 120
P: stimulating cell growth or inhibiting cell death;
N: inhibiting cell growth or enhancing cell death;
D: dual effects or unclear effects on cell growth or cell death.
doi:10.1371/journal.pone.0013558.t002
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mining factor in MSC differentiation, is the best candidate,
because it positively regulates adipogenesis but negatively regulates
osteogenesis by inhibiting the transcription of Runx2 as well as by
down-regulating BMPs expression [27–30]. Thus, we investigated
whether or not PPARc is a target gene of miR-20b.
We did so by using FindTar, a computational algorithm
developed in our Lab (http://bio.sz.tsinghua.edu.cn/lab/findtar)
[31], and found that miR-20b consisted of a highly probable
binding site at the 39UTR of PPARc (Fig. 3Ai). We then further
investigated the interaction between the 39UTR of PPARc and
miR-20b. The 39UTR of PPARc was inserted into a luciferase
expression vector to generate a luciferase reporter construct. The
miR-20b was then co-transfected with this reporter construct into
Cos-7 cells and the levels of luciferase activity were measured to
determine the corresponding repressive effects. Indeed, we
detected a significant repression in luciferase activity when miR-
20b was co-transfected with this vector expressing the 39UTR of
PPARc (Fig. 3Aii). To further confirm this direct interaction, the
binding site in PPARc 39UTR was mutated to generate another
reporter vector (Fig. 3Aiii). Such a mutation abolished the
repressive effects that miR-20b had on luciferase activity
(Fig. 3Ai), suggesting that miR-20b regulates PPARc expression
by directly binding to the 39UTR site of PPARc.
During the search for target genes of miR-20b by employing
such bioinformatics softwares as miRanda [32], Pictar [19],
TargetScan [33] and Findtar [31], two antagonists of the BMP
pathway, Bambi and Crim1, were also recognized as putative
target genes. To deduce the relationships between these two
antagonists and miR-20b, the 39UTR (i.e. 237 bp) of human
Bambi or the 39UTR (i.e. 174 bp) of human Crim1 were cloned
into the pRL-TK vector. As seen in Fig. 3Bi and Ci, both the
39UTRs contain putative binding sites for miR-20b. Cos-7 cells
were cotransfected with the vectors, negative control and miR-
20b, respectively. Cotransfection of miR-20b caused significant
reduction in total luciferase activity (Fig. 3Biii and Ciii). To further
demonstrate that an interaction exists between this miRNA and
Bambi or Crim1, the same 39UTR of Bambi or Crim1 was
mutated and cloned into the pRL-TK vector. Figure 3Bii and
Figure 3Cii shows the mutation we created on the binding sites of
the 39UTR of both Bambi and Crim1. Based on our results, this
mutation eliminated the repressive effect that miR-20b had on
luciferase activity(Fig. 3Bi and Ci). These results indicate that miR-
20b may directly target the 39UTRs of both Bambi and Crim1,
thus repressing their expression. Bambi is a pseudo-receptor of
BMP while Crim1 is an essential factor that tethers growth factors
including BMPs at the cell surface [30,34–36]. The down-
regulation of Bambi by miR-20b could perhaps free up more
BMP molecules that functional BMP receptors can then bind to,
thereby increasing the expression of Runx2. Suppression of Crim1
observed after the transfection of miR-20b resulted in an increase
in effective BMP concentrations in the media, which also affected
BMP processing and delivery to the cell surface. It has been
postulated that such an increase in free, mature and active BMPs
could activate BMP signaling, and thus enhance osteogenesis of
MSCs as demonstrated in our study.
In this study, we found that miR-20b enhanced osteogenesis by
activating the BMPs/Runx2 signaling pathway at four levels,
which consists of repressing PPARc, Bambi and Crim1(Fig. 4A).
However, we are curious whether or not miR-20b’s ability to
enhance osteogenesis is comparable to that of siRNAs of miR-
20b’s individual target genes in the BMPs/Runx2 signaling
pathway. Thus, we transfected hMSCs with the mimic of miR-
20b and the siRNAs for Alizarin red S staining (ARS staining).
The experiment showed that miR-20b induced a stronger change
in ARS staining than the siRNA (Figure 4B and 4C). This might
be due to the multi-target characteristics of miR-20b, which
siRNAs do not possess.
Taken together, miR-181b, miR-34a and miR-20b may have
provoked detectable functional changes by co-regulating func-
tionlly related gene groups or several genes in the same signaling
pathway. The accumulation of mild regulation from individual
miRNA targeting genes could have then lead to a detectable
change. This appears to be one of the modes of miRNA mediated
gene regulation.
Materials and Methods
Ethics statement
Human MSC was isolated from bone marrow collected from an
eighteen-year old healthy female donor under written consent by
the patient and under approval by The Chinese University of
Hong Kong- New Territories East Cluster Clinical Research
Ethics Committee.
Bioinformatic assay
The biologic data from investigations of genome-wide scale of
Bartels’ proteomic assay [1] and Nakagamas’ gene-expression
Figure 2. miR-20b activates BMP/Runx2 signaling pathway. (A) miR-20b mimic-transfected MSCs were collected at day 6. RT-PCR results
showed an up-regulation on the mRNA expression of BMP2 and Runx2 by miR-20b at day 6 in hMSCs respectively. (B) and (C) are the results of ELISA
analysis on the expression of BMP-2 and Runx2 on day 6 during osteogenesis after miR-20b transfection (n=4, *p,0.05, **p,0.01.) C: control; NC:
negative control (small RNA with random sequence); 20bI: miR-20b inhibitor.
doi:10.1371/journal.pone.0013558.g002
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PLoS ONE | www.plosone.org 4 October 2010 | Volume 5 | Issue 10 | e13558Figure 3. miR-20b activates BMP/Runx2 signaling pathway by down-regulating the expression of PPARc, Bambi and Crim1. A.
Predicted (Ai) and mutated (Aii) miR-20b binding sites in the 39UTR of PPARc. (Aiii) luciferase activity of the pRL-TK-PPARc report vector was inhibited
by miR-20b and the mutation on the binding sites of the 39UTR of PPARc eliminated the repressive effect of miR-20b (Aiv) (n=6; *p,0.05). p-p+NC:
pRL-TK-PPARc+ negative control; p-p+20b: pRL-TK-PPARc + miR-20b; p-p+20bI: pRL-TK-PPARc + miR-20b inhibitor. p-p-mut+NC: pRL-TK-PPARc
miRNA-Mediated Co-Regulation
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clustering, using the David tool (http://david.abcc.ncifcrf.gov/).
All significantly enriched GO terms (Benjamini-Hochberg cor-
rected p-values ,0.05) are shown in the Table S1 and Table S3.
Cell Growth and Death Assay
Hela cells (ATCC, VA), HCT116(IBMS of CAMS, China) cells,
and CNE cells of a nasopharyngeal carcinoma cell line (Kunming Cell
Bank, China) were seeded in 24-well culture plates (2610
4 cells /well)
and cultured in Dulbecco’s modified Eagle’s medium (DMEM),
Iscove’s Modified Dulbecco’s Medium (IMDM) and RPMI 1640
containing 10% fetal bovine serum (FBS) overnight, respectively. After
miRNA transfection and serum starvation, the cells were continuously
cultured in basal media with 2.0% FBS. After transfection, cells were
harvested and counted every day for 3 days. The average number of
cells was determined at each time point in triplicates.
Figure 4. miR-20b targeting several repressive genes in the BMPs/Runx2 pathway induces miR-20b-mediated osteogenesis in
hMSCs. (A) miR-20b enhanced osteogenesis of hMSCs by repressing the expression of inhibitors of the BMP/Runx2 signaling pathway in different
levels. (B) Comparison of ARS staining between miR-20b-transfected hMSCs and siRNA-transfected hMSCs (designed to target miR-20b’s target genes,
PPARr, Bambi and Crami). (C) Des-staining and OD measurement of ARS staining samples.
doi:10.1371/journal.pone.0013558.g004
mutation plasmid+ negative control; p-p-mut+20b: pRL-TK-PPARc mutation plasmid+miR-20b; p-p-mut+20bI: pRL-TK-PPARc mutation plasmid+miR-
20b inhibitor. B. Prediction (Bi) and mutation (Bii) of miR-20b binding sites in the 39UTRs of Bambi. (Biii) Luciferase activities of report vector with the
39UTR of Bambi were inhibited by miR-20b and the mutation on the binding sites of the 39UTR of Bambi (Biv) eliminated the repressive effect of miR-
20b (n=6; *p,0.05). C. Prediction (Ci) and mutation (Cii) of miR-20b binding sites in the 39UTRs of Crim1. (Ciii) Luciferase activities of report vector
with the 39UTR of Crim1 were inhibited by miR-20b and the mutation on the binding sites of the 39UTR of Crim1 (Civ) eliminated the repressive effect
of miR-20b (n=6; **p,0.01). p-B/p-C+NC: pRL-TK-Bambi/pRL-TK-Crim1 plasmid + negative control; p-B/p-C+20b: pRL-TK-Bambi/pRL-TK-Crim1 plasmid
+ miR-20b; p-B/p-C+20bI: pRL-TK-Bambi/pRL-TK-Crim1 plasmid + miR-20b inhibitor. p-B-mut/p-C-mut+NC: pRL-TK-Bambi/pRL-TK-Crim1mutation
plasmid + negative control; p-B-mut/p-C-mut+20b: pRL-TK-Bambi /pRL-TK- Crim1 mutation plasmid + miR-20b; p-B-mut/p-C-mut+20bI: pRL-TK-Bambi/
pRL-TK- Crim1 mutation plasmid + miR-20b inhibitor.
doi:10.1371/journal.pone.0013558.g003
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differentiation
Bone marrow was collected from an eighteen-year old healthy
female donor. hMSCs were isolated and identified by cell surface
markers, then, cultured in Minimum Essential Medium Alpha
Medium (a-MEM) supplemented with 10% FBS, 2 mM L-
Glutamine, 100 U/mL penicillin and 100 mg/mL streptomycin,
and incubated in a humidified atmosphere of 5% CO2 at 37uC.
After four cell passages, cell surface markers, CD3, CD16, CD19,
CD33, CD34, CD38, CD45, CD133, HLA-DR, CD29, CD44,
CD90, CD105 and CD166 were assayed. Osteogenic differenti-
ation of MSCs was induced according to a previously published
protocol. OS medium was supplemented with osteogenic inducers,
including 10
28 M dexamethasone (Dex), 10 mg/mL L-ascorbic
acid 2-phosphate (AsAP) and 10 mM Glycerol 2-phosphate (Gly)
(Sigma, USA).
miRNAs transfection
miRNA mimics were designed according to the miRBase
sequence database (http://microrna.sanger.ac.uk). miRNA mim-
ics and siRNAs duplexes of PPARc, Bambi, crim1 were
synthesized by Shanghai GenePharma Co. (Shanghai, China).
siRNA duplexes consisting of random sequence were used as
negative controls (NC). The Table S5 shows the sequence of
miRNA and siRNAs. Hela cells, CNE cells and hMSCs were
seeded onto 96- or 24-well plates and transfected with siRNA/
miRNAs duplexes using Lipofectaime 2000 (Invitrogen Corp.,
Carlsbad, CA) according to manufacturer’s instructions. The
medium was replaced 6 hours later.
ARS staining
MSCs were fixed in 4% paraformaldehyde (m/v) for 10 min,
and samples were evaluated by ARS. Briefly, cells were stained
with 2% ARS (pH 4.1) for 15 min and then washed with
deionized water twice. The orange and red positions in ARS
staining were recognized as calcium deposits.
Reverse transcriptase - polymerase chain reaction
(RT-PCR)
hMSCs were harvested and the total RNA was extracted using
Trizol reagent (Invitrogen, USA) according to the manufacturer’s
protocol. RT-PCR was performed with the total RNA using
TaKaRa one step RNA PCR kit (TaKaRa Bio Inc, Japan).
Primers were designed by the website: http://frodo.wi.mit.edu/
based on the mRNA sequences obtained from Genebank
(Table S6).
Enzyme-linked immunosorbent assay (ELISA)
ELISA Kits from the R&D system (Minneapolis, MN) were
used for ELISA assays of BMP-2 and Runx2. Briefly, the cell lysate
of MSCs was added to the coated wells of a 96-well plate, then
incubated with HRP-linked antibody at 37uC for 30 min after
washing with washing buffer. Absorbance was determined at
450 nm on the microplate spectrophotometer (TECAN). Each
experiment was done in quadruplets.
Luciferase Assays
Reporter vectors were generated by inserting the 39UTRs of
Bambi (nt 14–250), Crim1 (nt 1584–1758) and PPARc (nt 23–207)
and their corresponding mutated 39UTR fragments into pRL-TK
plasmid (Promega, USA). 39UTRs were amplified by PCR using
the primers shows in Table S1. Luciferase assays were performed
according to a previously published protocol [31]. Briefly, Cos-7
cells were seeded onto 24-well plates and cotransfection was
performed using 300 ng of plasmid and 20 nm of each miRNA
using Lipofectamine 2000, the next day. Cell lysates were collected
after 30 h of transfection. Renilla luciferase activity were measured
using a Luciferase Reporter Assay System (Promega, USA) and
each experiment was repeated in three times. Total protein
concentrations were determined at 595 nm using Bradford assay
(Bio-Rad) on a spectrophotometer (TECAN). The luciferase
activity was normalized by the total protein content.
Statistical analysis
Data are expressed as mean 6 SD. Statistical analysis was
performed using the independent simplest-test (SPSS, USA). A p-
value less than 0.05 was considered statistically significant.
Supporting Information
Table S1 The functional annotation clusters related to cell
growth and cell death in miR-181b regulated genes.
Found at: doi:10.1371/journal.pone.0013558.s001 (0.24 MB
DOC)
Table S2 miR-181b regulated genes related to cell growth and
cell death.
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Table S4 miR-34a regulated genes related to cell growth and
cell death.
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